He et al. demonstrated that ChaihuShugan powder, an anxiety treatment prescription, could increase the protein and mRNA expression of CYP3A4 by activating the progesterone X receptor (PXR) pathway in a mouse model of depression (He et al., 2019). Here, NR1I2 is linked to depressive symptom measurement.